Published in Women's Health Weekly, November 8th, 2007
"This study evaluates the concordance between HER2 gene amplification in invasive breast cancer determined by fluorescence in. situ hybridisation (FISH) and a new silver enhanced in situ hybridisation (SISH) technique. Ninety-nine cases were analysed by direct-labelled manual FISH (PathVysion (R), Abbott/Vysis) and bright field automated SISH (INFORM (R), Ventana). For comparison, all specimens were stained by immunohistochemistry (Dako-HercepTest (TM) and Ventana-PATHWAY (R) 4B5)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly